Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Evolution of neoplastic cell lineages in Barrett oesophagus

Abstract

It has been hypothesized that neoplastic progression develops as a consequence of an acquired genetic instability and the subsequent evolution of clonal populations with accumulated genetic errors1. Accordingly, human cancers and some premalignant lesions contain multiple genetic abnormalities not present in the normal tissues from which the neoplasms arose2,3. Barrett oesophagus (BE) is a premalignant condition which predisposes to oesophageal adenocarcinoma (EA) that can be biopsied prospectively over time because endoscopic surveillance is recommended for early detection of cancer4,5. In addition, oesophagectomy specimens frequently contain the premalignant epithelium from which the cancer arose6. Neoplastic progression in BE is associated with alterations in TP53 (also known as p53) and CDKN2A (also known as p16) and non-random losses of heterozygosity7,8,9,10,11 (LOH). Aneuploid or increased 4N populations occur in more than 90-95% of EAs, arise in premalignant epithelium and predict progression10,12,13. We have previously shown in small numbers of patients that disruption of TP53 and CDKN2A typically occurs before aneuploidy and cancer10,11,14,15. Here, we determine the evolutionary relationships of non-random LOH, TP53 and CDKN2A mutations, CDKN2A CpG-island methylation and ploidy during neoplastic progression. Diploid cell progenitors with somatic genetic or epigenetic abnormalities in TP53 and CDKN2A were capable of clonal expansion, spreading to large regions of oesophageal mucosa. The subsequent evolution of neoplastic progeny frequently involved bifurcations and LOH at 5q, 13q and 18q that occurred in no obligate order relative to each other, DNA-content aneuploidy or cancer. Our results indicate that clonal evolution is more complex than predicted by linear models.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Clonal evolution in patients with BE in vivo.
Figure 2: Multiple genetic routes to cancer in BE.

Similar content being viewed by others

References

  1. Nowell, P.C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).

    Article  CAS  Google Scholar 

  2. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).

    Article  CAS  Google Scholar 

  3. Boland, C.R., Sato, J., Appelman, H.D., Besalier, R.S. & Feinberg, A.P. Microallelotyping defines the sequence and tempo of allelic losses at tumor suppressor gene loci during colorectal cancer progression. Nature Med. 1, 902–909 (1995).

    Article  CAS  Google Scholar 

  4. Spechler, S.J. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann. Intern. Med. 106, 902–904 (1987).

    Article  CAS  Google Scholar 

  5. Levine, D.S. et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105, 40–50 (1993).

    Article  CAS  Google Scholar 

  6. Rabinovitch, P.S., Reid, B.J., Haggitt, R.C., Norwood, T.H. & Rubin, C.E. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab. Invest. 60, 65–71 (1989).

    CAS  PubMed  Google Scholar 

  7. Neshat, K. et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 106, 1589–1595 (1994).

    Article  CAS  Google Scholar 

  8. Barrett, M.T., Galipeau, P.C., Sanchez, C.A., Emond, M.J. & Reid, B.J. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12, 1873–1878 (1996).

    CAS  PubMed  Google Scholar 

  9. Wong, D.J., Barrett, M.T., Stoger, R., Emond, M.J. & Reid, B.J. p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res. 57, 2619–2622 (1997).

    CAS  PubMed  Google Scholar 

  10. Galipeau, P.C. et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc. Natl Acad. Sci. USA 93, 7081–7084 (1996).

    Article  CAS  Google Scholar 

  11. Barrett, M.T. et al. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 13, 1867–1873 (1996).

    CAS  PubMed  Google Scholar 

  12. Reid, B.J., Haggitt, R.C., Rubin, C.E. & Rabinovitch, P.S. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93, 1–11 (1987).

    Article  CAS  Google Scholar 

  13. Reid, B.J. et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 102, 1212–1219 (1992).

    Article  CAS  Google Scholar 

  14. Blount, P.L. et al. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc. Natl Acad. Sci. USA 90, 3221–3225 (1993).

    Article  CAS  Google Scholar 

  15. Blount, P.L. et al. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res. 54, 2292–2295 (1994).

    CAS  PubMed  Google Scholar 

  16. Mao, L. et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl Cancer Inst. 89, 857–862 (1997).

    Article  CAS  Google Scholar 

  17. Bedi, G.C., Westra, W.H., Gabrielson, E., Koch, W. & Sidransky, D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 56, 2484–2487 (1996).

    CAS  PubMed  Google Scholar 

  18. Califano, J. et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56, 2488–2492 (1996).

    CAS  PubMed  Google Scholar 

  19. Sidransky, D. et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355, 846–847 (1992).

    Article  CAS  Google Scholar 

  20. Gazdar, A.F. et al. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb. Symp. Quant. Biol. 59, 565–572 (1994).

    Article  CAS  Google Scholar 

  21. Kuukasjarvi, T. et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57, 1597–1604 (1997).

    CAS  PubMed  Google Scholar 

  22. Wu, T. et al. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am. J. Pathol. 153, 287–294 (1998).

    Article  CAS  Google Scholar 

  23. van der Burgh, A., Dees, J., Hop, W.C.J. & van Blankenstein, M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 39, 5–8 (1996).

    Article  CAS  Google Scholar 

  24. Mao, L. et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl Cancer Inst. 89, 857–862 (1997).

    Article  CAS  Google Scholar 

  25. Correa, P. et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 50, 4737–4740 (1990).

    CAS  PubMed  Google Scholar 

  26. Rozen, P., Baratz, M., Fefer, F. & Gilat, T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 108, 1361–1370 (1995).

    Article  CAS  Google Scholar 

  27. Eide, T.J. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int. J. Cancer 38, 173–176 (1985).

    Article  Google Scholar 

  28. Petersen, S.E., Lorentzen, M. & Bichel, P. A mosaic subpopulation structure of human colorectal carcinomas demonstrated by flow cytometry. Flow Cytometry IV, 412–416 (1980).

    Google Scholar 

  29. Barrett, M.T., Schutte, M., Kern, S.E. & Reid, B.J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res. 56, 4351–4353 (1996).

    CAS  PubMed  Google Scholar 

  30. Levine, D.S. et al. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 101, 1198–1210 (1991).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank D. Levine, R. Haggitt and P. Blount for contributions to the Seattle Barrett's Esophagus Study, G. Longton for statistical analysis and L. Hartwell, C. Kemp, M. Groudine and S. Friend for reviewing this manuscript. Supported by NIH Grants RO1CA61202, DK07742-03 (T.G.P.), ACS Grant RPG-87-0060120CCE and Poncin Scholarship Fund (D.J.W.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian J. Reid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barrett, M., Sanchez, C., Prevo, L. et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22, 106–109 (1999). https://doi.org/10.1038/8816

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/8816

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing